GGrantIndex
← Leaderboards

Victor G. Davila-Roman

Universidad Peruana Cayetano Heredia

$19,844,708
Attributed
$42,242,826
Total exposure
21
Grants
9
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $6M · FY200525
$10M$7.5M$5M$2.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$42,242,826 · 21

By mechanism

U24$9,471,643 · 1
R01$8,291,747 · 4
UH3$6,341,889 · 2
R25$4,482,406 · 2
U10$3,532,879 · 1
UG3$2,708,917 · 2

Most similar at Universidad Peruana Cayetano Heredia

Same institution · by research overlap

Others in their field

Top investigators on “Universities

Research focus

UniversitiesWashingtonFundingTrainingProgramsPublic HealthFacultyMentorsLeadershipResearch Project GrantsHypertensionResearch PersonnelClinical ResearchNational Heart, Lung, And Blood InstituteAreaUnited States National Institutes Of HealthResponseGrantCollaborationsCardiovascular DiseasesImplementation ScienceCareerResearch TrainingInnovation

Grant awards (77)

Addressing HyperteNsion and Diabetes through Community-Engaged Systems in Puno Peru (ANDES study)$1,405,550
UH3 · FY2025 · HL
Enhancing Cardiovascular Health in Mothers and Children Through Home Visiting$960,108
UH3 · FY2025 · HL
ENhancing Intergenerational HeAlth in Nigeria: Peripartum as Critical Life StagE for CardioVascular Health (ENHANCE-CVH)$359,120
R01 · FY2025 · HL
Research Training in Data Science for Health in Rwanda$350,000
U2R · FY2025 · TW
PRIDE Summer Institute in Cardiovascular Disease Comorbidities, Genetics and Epidemiology (CVD-CGE)$342,334
R25 · FY2025 · HL · contact PI
Research Training: Chronic Non-Communicable CVDs and Comorbidities in Peru$247,815
D43 · FY2025 · TW
ENhancing Intergenerational HeAlth in Nigeria: Peripartum as Critical Life StagE for CardioVascular Health (ENHANCE-CVH)$217,029
R01 · FY2025 · HL
Enhancing Cardiovascular Health in Mothers and Children Through Home Visiting$211,210
UH3 · FY2025 · HL
SYNthetic Healthcare DAta Platform for Data SciEnce Training ("SYNAPSE")$199,646
UE5 · FY2025 · HL
Washington University SummeR reseArch DIversity ProgrAm iN Cardiovascular Disease & HEmatology (RADIANCE)$165,566
R25 · FY2025 · HL · contact PI
Implementation Research Strategies for Heart, Lung, and Blood Co-morbidities in People Living with HIV - Research Coordinating Center$1,390,898
U24 · FY2024 · HL
Addressing HyperteNsion and Diabetes through Community-Engaged Systems in Puno Peru (ANDES study)$1,386,598
UH3 · FY2024 · HL
Enhancing Cardiovascular Health Equity in Mothers and Children Through Home Visiting$955,765
UH3 · FY2024 · HL
ENhancing Intergenerational HeAlth in Nigeria: Peripartum as Critical Life StagE for CardioVascular Health (ENHANCE-CVH)$562,259
R01 · FY2024 · HL
Research Training in Data Science for Health in Rwanda$350,000
U2R · FY2024 · TW · contact PI
PRIDE Summer Institute in Cardiovascular Disease Comorbidities, Genetics and Epidemiology (CVD-CGE)$342,360
R25 · FY2024 · HL · contact PI
Research Training: Chronic Non-communicable CVDs and Comorbidities in Peru$247,325
D43 · FY2024 · TW
SYNthetic Healthcare DAta Platform for Data SciEnce Training ("SYNAPSE")$199,646
UE5 · FY2024 · HL
Washington University SummeR reseArch DIversity ProgrAm iN Cardiovascular Disease & HEmatology (RADIANCE)$165,837
R25 · FY2024 · HL · contact PI
Implementation Research Strategies for Heart, Lung, and Blood Co-morbidities in People Living with HIV - Research Coordinating Center$1,914,241
U24 · FY2023 · HL
Addressing HyperteNsion and Diabetes through Community-Engaged Systems in Puno Peru (ANDES study)$1,422,658
UH3 · FY2023 · HL
Enhancing Cardiovascular Health Equity in Mothers and Children Through Home Visiting$796,906
UG3 · FY2023 · HL
ENhancing Intergenerational HeAlth in Nigeria: Peripartum as Critical Life StagE for CardioVascular Health (ENHANCE-CVH)$617,146
R01 · FY2023 · HL
Research Training in Data Science for Health in Rwanda$350,000
U2R · FY2023 · TW · contact PI
PRIDE Summer Institute in Cardiovascular Disease Comorbidities, Genetics and Epidemiology (CVD-CGE)$333,537
R25 · FY2023 · HL
Research Training: Chronic Non-communicable CVDs and Comorbidities in Peru$247,983
D43 · FY2023 · TW
SYNthetic Healthcare DAta Platform for Data SciEnce Training ("SYNAPSE")$200,000
UE5 · FY2023 · HL
Washington University SummeR reseArch DIversity ProgrAm iN Cardiovascular Disease & HEmatology (RADIANCE)$166,078
R25 · FY2023 · HL · contact PI
Implementation Research Strategies for Heart, Lung, and Blood Co-morbidities in People Living with HIV - Research Coordinating Center$1,914,241
U24 · FY2022 · HL
Supplement: Implementation Research Strategies for Heart, Lung, and Blood Co-morbidities in People Living with HIV - Research Coordinating Center$752,070
U24 · FY2022 · HL
Enhancing Cardiovascular Health Equity in Mothers and Children Through Home Visiting$635,923
UG3 · FY2022 · HL
PRIDE Summer Institute in Cardiovascular Disease Comorbidities, Genetics and Epidemiology (CVD-CGE)$460,777
R25 · FY2022 · HL
Research Training in Data Science for Health in Rwanda$349,999
U2R · FY2022 · TW · contact PI
Research Training: Chronic Non-communicable CVDs and Comorbidities in Peru$249,339
D43 · FY2022 · TW
Washington University SummeR reseArch DIversity ProgrAm iN Cardiovascular Disease & HEmatology (RADIANCE)$166,320
R25 · FY2022 · HL · contact PI
Implementation Research Strategies for Heart, Lung, and Blood Co-morbidities in People Living with HIV - Research Coordinating Center$1,990,173
U24 · FY2021 · HL
Addressing HyperteNsion and Diabetes through Community-Engaged Systems in Puno, Peru (ANDES study)$635,044
UG3 · FY2021 · HL
PRIDE Summer Institute in Cardiovascular Disease Comorbidities, Genetics and Epidemiology (CVD-CGE)$463,790
R25 · FY2021 · HL
Washington University K12 Program in T4 Implementation Research$416,548
K12 · FY2021 · HL · contact PI
Research Training in Data Science for Health in Rwanda$349,999
U2R · FY2021 · TW · contact PI
Research Training: Chronic Non-communicable CVDs and Comorbidities in Peru$251,237
D43 · FY2021 · TW
Implementation Research Strategies for Heart, Lung, and Blood Co-morbidities in People Living with HIV - Research Coordinating Center$1,510,020
U24 · FY2020 · HL
Washington University K12 Program in T4 Implementation Research$981,115
K12 · FY2020 · HL · contact PI
Addressing HyperteNsion and Diabetes through Community-Engaged Systems in Puno, Peru (ANDES study)$641,044
UG3 · FY2020 · HL
PRIDE Summer Institute in Cardiovascular Disease Comorbidities, Genetics and Epidemiology (CVD-CGE)$466,309
R25 · FY2020 · HL
Washington University K12 Program in T4 Implementation Research$1,008,597
K12 · FY2019 · HL · contact PI
PRIDE Summer Institute in Cardiovascular Disease Comorbidities, Genetics and Epidemiology (CVD-CGE)$469,723
R25 · FY2019 · HL
ULTRASOUND SYSTEM FOR CARDIOVASCULAR PHENOTYPE STUDIES IN HUMANS$215,487
S10 · FY2019 · OD · contact PI
SALsalate to Improve Exercise toleraNce and LVDD in T2dm-DHF (SALIENT-DHF trial)$500,983
U10 · FY2018 · HL
SALsalate to Improve Exercise toleraNce and LVDD in T2dm-DHF (SALIENT-DHF trial)$500,983
U10 · FY2017 · HL
PRIDE SUMMER INSTITUTE IN CARDIOVASCULAR GENETIC EPIDEMIOLOGY$330,007
R25 · FY2017 · HL
SALsalate to Improve Exercise toleraNce and LVDD in T2dm-DHF (SALIENT-DHF trial)$500,983
U10 · FY2016 · HL
PRIDE SUMMER INSTITUTE IN CARDIOVASCULAR GENETIC EPIDEMIOLOGY$1
R25 · FY2016 · HL
SALsalate to Improve Exercise toleraNce and LVDD in T2dm-DHF (SALIENT-DHF trial)$500,983
U10 · FY2015 · HL
PRIDE SUMMER INSTITUTE IN CARDIOVASCULAR GENETIC EPIDEMIOLOGY$319,099
R25 · FY2015 · HL
SALsalate to Improve Exercise toleraNce and LVDD in T2dm-DHF (SALIENT-DHF trial)$502,354
U10 · FY2014 · HL
PRIDE SUMMER INSTITUTE IN CARDIOVASCULAR GENETIC EPIDEMIOLOGY$290,668
R25 · FY2014 · HL
SALsalate to Improve Exercise toleraNce and LVDD in T2dm-DHF (SALIENT-DHF trial)$510,602
U10 · FY2013 · HL
SALsalate to Improve Exercise toleraNce and LVDD in T2dm-DHF (SALIENT-DHF trial)$515,991
U10 · FY2012 · HL
Physical Frailty in Urban African-Americans$753,623
R01 · FY2011 · AG · contact PI
GENETIC DETERMINANTS OF THE LVH PHENOTYPE$937,040
R01 · FY2010 · HL · contact PI
GENETIC DETERMINANTS OF THE LVH PHENOTYPE$911,932
R01 · FY2009 · HL · contact PI
Physical Frailty in Urban African-Americans$379,879
R01 · FY2009 · AG
ULTRASOUND SYSTEM FOR CARDIOVASCULAR PHENOTYPE STUDIES IN HUMANS$236,625
S10 · FY2009 · RR · contact PI
Genetic Determinants of the LVH Phenotype$702,258
R01 · FY2006 · HL · contact PI
Cardiac Function and Metabolism in Hypertension$130,350
K24 · FY2006 · HL · contact PI
Genetic Determinants of the LVH Phenotype$715,333
R01 · FY2005 · HL
Cardiac Function and Metabolism in Hypertension$130,380
K24 · FY2005 · HL
Genetic Determinants of the LVH Phenotype$711,074
R01 · FY2004 · HL
Cardiac Function and Metabolism in Hypertension$130,406
K24 · FY2004 · HL
Blood Flow, Contractile and Metabolic Function in LVH.$319
M01 · FY2004 · RR
Genetic Determinants of the LVH Phenotype$693,145
R01 · FY2003 · HL
Cardiac Function and Metabolism in Hypertension$130,429
K24 · FY2003 · HL
Cardiac Function and Metabolism in Hypertension$130,600
K24 · FY2002 · HL
BLOOD FLOW, CONTRACTILE AND METABOLIC FUNCTION IN LVH$369,443
R01 · FY2001 · HL
BLOOD FLOW, CONTRACTILE AND METABOLIC FUNCTION IN LVH$362,466
R01 · FY2000 · HL
ULTRASOUND SYSTEM FOR CLINICAL CARDIOVASCULAR USE$309,500
S10 · FY2000 · RR